Skip to main content

MoneyWorks4Me

Shardaben Gulabdas Patel submits disclosure

31 Mar 2018 Evaluate

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shardaben Gulabdas Patel.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..